Ekachai Medical Care Public Company Limited

As of June 30, 2026, Ekachai Medical Care Public Company Limited carries a market capitalization of 3.98B, placing it among publicly traded companies globally. Its enterprise value stands at 3.60B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Ekachai Medical Care Public Company Limited's next confirmed earnings release is scheduled for November 18, 2026.

As of June 30, 2026, Ekachai Medical Care Public Company Limited has 800.00M shares outstanding.

As of June 30, 2026, Ekachai Medical Care Public Company Limited trades at a trailing price-to-earnings ratio of 14.70. The price-to-sales ratio is 3.07, and the price-to-book ratio stands at 1.78.

As of June 30, 2026, Ekachai Medical Care Public Company Limited trades at an EV/EBITDA multiple of 8.15 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.77 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 9.96 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 3.60B versus a market cap of 3.98B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Ekachai Medical Care Public Company Limited maintains a current ratio of 3.85, meaning it holds 3.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.52, indicating elevated leverage, while an interest coverage ratio of 124.75 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Ekachai Medical Care Public Company Limited posted a return on equity (ROE) of 12.06, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 11.54 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 9.69, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 9.65, useful for judging operating efficiency across full business cycles. The company generates approximately 2.15M in revenue per employee across its workforce of 605.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 19.48 indicates how many times Ekachai Medical Care Public Company Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Ekachai Medical Care Public Company Limited recorded 68.62M in income tax expense. That works out to an effective tax rate of 18.57, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 369.45M, leaving 271.05M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Ekachai Medical Care Public Company Limited's stock has declined approximately 0.96% over the past 52 weeks. The 50-day moving average sits at 5.16, while the 200-day moving average is 5.04.

Over the twelve months ended June 30, 2026, Ekachai Medical Care Public Company Limited generated 1.30B in revenue and converted that into 271.05M in net income, yielding earnings per share of 0.38. EBITDA reached 441.77M, while operating income came in at 324.60M.

As of June 30, 2026, Ekachai Medical Care Public Company Limited holds 711.89M in cash and equivalents against 63.19M in total debt, resulting in a net debt position of -506.65M. Total book value stands at 2.24B, with working capital of 691.20M providing operational flexibility.

Ekachai Medical Care Public Company Limited produced 369.68M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -567.25M in capital expenditures, free cash flow totaled -197.57M - equivalent to -0.25 per share.

Over the twelve months ended June 30, 2026, Ekachai Medical Care Public Company Limited posted a gross margin of 42.19, reflecting its pricing power and cost economics. The operating margin of 24.99 and net profit margin of 20.86 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Ekachai Medical Care Public Company Limited paid dividends of -NaN per share. The dividend payout ratio of 0.00 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -4.96: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 5.59, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Ekachai Medical Care Public Company Limited shareholders.

Ekachai Medical Care Public Company Limited's most recent stock split took place on May 7, 2024 with a 40:41 split ratio.

As of June 30, 2026, Ekachai Medical Care Public Company Limited has an Altman Z-Score of 8.16, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.